Group One Trading’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $554K | Buy |
2,841
+1,275
| +81% | +$264K | ﹤0.01% | 3398 |
|
|
2026
Q1 | $352K | Buy |
1,566
+1,416
| +944% | +$353K | ﹤0.01% | 3661 |
|
|
2025
Q4 | $36.1K | Buy |
+150
| New | +$38.4K | ﹤0.01% | 5867 |
|
|
2025
Q3 | – | Sell |
-5,292
| Closed | -$1.45M | – | 9040 |
|
|
2025
Q2 | $1.37M | Buy |
5,292
+2,913
| +122% | +$695K | ﹤0.01% | 2483 |
|
|
2025
Q1 | $533K | Sell |
2,379
-7,113
| -75% | -$1.66M | ﹤0.01% | 3026 |
|
|
2024
Q4 | $2.17M | Buy |
9,492
+2,640
| +39% | +$636K | 0.01% | 1838 |
|
|
2024
Q3 | $1.67M | Buy |
+6,852
| New | +$1.53M | ﹤0.01% | 1864 |
|
|
2024
Q1 | – | Sell |
-7,483
| Closed | -$1.37M | – | 7831 |
|
|
2023
Q4 | $1.29M | Buy |
7,483
+7,442
| +18,151% | +$1.14M | ﹤0.01% | 2240 |
|
|
2023
Q3 | $6.06K | Buy |
+41
| New | +$7.41K | ﹤0.01% | 6601 |
|
|
2022
Q2 | – | Sell |
-96
| Closed | -$20.4K | – | 8416 |
|
|
2022
Q1 | $23K | Sell |
96
-855
| -90% | -$207K | ﹤0.01% | 6672 |
|
|
2021
Q4 | $248K | Sell |
951
-638
| -40% | -$166K | ﹤0.01% | 4875 |
|
|
2021
Q3 | $419K | Sell |
1,589
-223
| -12% | -$61K | ﹤0.01% | 4396 |
|
|
2021
Q2 | $447K | Buy |
+1,812
| New | +$381K | ﹤0.01% | 4333 |
|
|
2020
Q4 | – | Sell |
-14,546
| Closed | -$2.9M | – | 6928 |
|
|
2020
Q3 | $2.49M | Buy |
14,546
+13,764
| +1,760% | +$2.54M | 0.01% | 1427 |
|
|
2020
Q2 | $150K | Sell |
782
-548
| -41% | -$89.7K | ﹤0.01% | 3608 |
|
|
2020
Q1 | $196K | Buy |
1,330
+500
| +60% | +$79.6K | ﹤0.01% | 2767 |
|
|
2019
Q4 | $129K | Buy |
+830
| New | +$120K | ﹤0.01% | 3476 |
|
|
2019
Q3 | – | Sell |
-119
| Closed | -$15.6K | – | 5469 |
|
|
2019
Q2 | $15K | Buy |
+119
| New | +$13.2K | ﹤0.01% | 4284 |
|
|
2018
Q1 | – | Sell |
-250
| Closed | -$23.6K | – | 5242 |
|
|
2017
Q4 | $21K | Sell |
250
-198
| -44% | -$16.4K | ﹤0.01% | 4136 |
|
|
2017
Q3 | $34K | Sell |
448
-4,115
| -90% | -$315K | ﹤0.01% | 3824 |
|
|
2017
Q2 | $355K | Buy |
4,563
+3,462
| +314% | +$248K | ﹤0.01% | 2212 |
|
|
2017
Q1 | $79K | Buy |
+1,101
| New | +$76.1K | ﹤0.01% | 3121 |
|
|
2016
Q1 | – | Sell |
-12,343
| Closed | -$699K | – | 4881 |
|
|
2015
Q4 | $663K | Sell |
12,343
-2,107
| -15% | -$119K | 0.01% | 1598 |
|
|
2015
Q3 | $736K | Buy |
14,450
+6,594
| +84% | +$355K | 0.01% | 1485 |
|
|
2015
Q2 | $443K | Buy |
+7,856
| New | +$496K | 0.01% | 1884 |
|
|
2014
Q1 | – | Sell |
-5,751
| Closed | -$258K | – | 5522 |
|
|
2013
Q4 | $271K | Buy |
+5,751
| New | +$291K | ﹤0.01% | 2168 |
|
Other funds holding RMD
Group One Trading's RMD Position: Q2 2026 in Review
Group One Trading increased its ResMed (RMD) stake by 81% in Q2 2026, buying an estimated $264K and bringing the position to 2,841 shares worth $554K. The position accounts for ﹤0.01% of the portfolio, ranked #3398.
Group One Trading first reported a position in RMD in Q4 2013 and has held it in 26 quarters since. The position peaked at $2.49M in Q3 2020. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Group One Trading held 2,841 shares of ResMed worth $554K as of Q2 2026.
- Group One Trading bought 1,275 ResMed shares in Q2 2026, an estimated $264K.
- ResMed made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #3398 holding.
- Group One Trading first reported a position in ResMed in Q4 2013 and has held it in 26 quarters since.
- Group One Trading's ResMed position peaked at $2.49M in Q3 2020.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.